112 related articles for article (PubMed ID: 17113653)
1. Lactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis rats.
Zimecki M; Kocieba M; Chodaczek G; Houszka M; Kruzel ML
J Neuroimmunol; 2007 Jan; 182(1-2):160-6. PubMed ID: 17113653
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
[TBL] [Abstract][Full Text] [Related]
3. Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production.
Lavrnja I; Stojkov D; Bjelobaba I; Pekovic S; Dacic S; Nedeljkovic N; Mostarica-Stojkovic M; Stosic-Grujicic S; Rakic L; Stojiljkovic M
Int Immunopharmacol; 2008 Sep; 8(9):1282-90. PubMed ID: 18602075
[TBL] [Abstract][Full Text] [Related]
4. [1, 25-dihydroxyvitamin D3 promotes the apoptosis of inflammatory cells in acute experimental autoimmune encephalomyelitis: experiment with rats].
Jiao ZM; Fu YH; Fu J; Zhang F; Wang WZ
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2350-4. PubMed ID: 19087699
[TBL] [Abstract][Full Text] [Related]
5. Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE).
Corrêa JO; Aarestrup BJ; Aarestrup FM
Exp Neurol; 2010 Nov; 226(1):15-23. PubMed ID: 20406639
[TBL] [Abstract][Full Text] [Related]
6. Neurointermediate pituitary lobectomy decreases the incidence and severity of experimental autoimmune encephalomyelitis in Lewis rats.
Quintanar-Stephano A; Chavira-Ramírez R; Kovacs K; Berczi I
J Endocrinol; 2005 Jan; 184(1):51-8. PubMed ID: 15642782
[TBL] [Abstract][Full Text] [Related]
7. Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1.
Kang JC; Ahn M; Kim YS; Moon C; Lee Y; Wie MB; Lee YJ; Shin T
J Vet Sci; 2001 Aug; 2(2):85-9. PubMed ID: 14614276
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist.
Wiemann B; Van GY; Danilenko DM; Yan Q; Matheson C; Munyakazi L; Ogenstad S; Starnes CO
Exp Neurol; 1998 Feb; 149(2):455-63. PubMed ID: 9500957
[TBL] [Abstract][Full Text] [Related]
9. Increased phosphorylation of caveolin-1 in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis.
Kim H; Ahn M; Lee J; Moon C; Matsumoto Y; Koh CS; Shin T
Neurosci Lett; 2006 Jul; 402(1-2):76-80. PubMed ID: 16678345
[TBL] [Abstract][Full Text] [Related]
10. Increased phosphorylation of cyclic AMP response element-binding protein in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis.
Kim H; Moon C; Ahn M; Lee Y; Kim S; Matsumoto Y; Koh CS; Kim MD; Shin T
Brain Res; 2007 Aug; 1162():113-20. PubMed ID: 17617386
[TBL] [Abstract][Full Text] [Related]
11. Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats.
Moriya M; Nakatsuji Y; Okuno T; Hamasaki T; Sawada M; Sakoda S
J Neuroimmunol; 2005 Dec; 170(1-2):11-20. PubMed ID: 16146654
[TBL] [Abstract][Full Text] [Related]
12. Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis.
Shin T; Kim H; Jin JK; Moon C; Ahn M; Tanuma N; Matsumoto Y
J Neuroimmunol; 2005 Aug; 165(1-2):11-20. PubMed ID: 15925413
[TBL] [Abstract][Full Text] [Related]
13. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats.
Núñez MJ; Balboa J; Rey-Méndez M; Brenlla J; González-Peteiro M; Rodrigo E; Freire-Garabal M
Hum Exp Toxicol; 2007 Aug; 26(8):637-43. PubMed ID: 17884951
[TBL] [Abstract][Full Text] [Related]
14. [Inhibiton of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99].
Sun B; Yang S; Peng HS; Qiao H; Cao JY; Jin LH; Li HL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):106-9. PubMed ID: 17286899
[TBL] [Abstract][Full Text] [Related]
15. RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis.
DeVry CG; Valdez M; Gao L; Wang J; Kotsch K; Volk HD; Bechmann I; Buelow R; Iyer S
J Neuroimmunol; 2004 Jul; 152(1-2):33-43. PubMed ID: 15223235
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of flotillin-1 in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitis.
Kim H; Ahn M; Moon C; Matsumoto Y; Sung Koh C; Shin T
Brain Res; 2006 Oct; 1114(1):204-11. PubMed ID: 16919610
[TBL] [Abstract][Full Text] [Related]
17. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.
Linker RA; Lühder F; Kallen KJ; Lee DH; Engelhardt B; Rose-John S; Gold R
J Neuroimmunol; 2008 Dec; 205(1-2):64-72. PubMed ID: 18950871
[TBL] [Abstract][Full Text] [Related]
18. The presence of GM-CSF and IL-4 interferes with effect of TGF-beta1 on antigen presenting cells in patients with multiple sclerosis and in rats with experimental autoimmune encephalomyelitis.
Xiao BG; Zhu WH; Lu CZ
Cell Immunol; 2007 Sep; 249(1):30-6. PubMed ID: 18061154
[TBL] [Abstract][Full Text] [Related]
19. Normalization of peripheral blood cell composition by lactoferrin in cyclophosphamide-treated mice.
Artym J; Zimecki M; Kruzel M
Med Sci Monit; 2004 Mar; 10(3):BR84-9. PubMed ID: 14976460
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental autoimmune encephalomyelitis by dermatan sulfate.
Inaba Y; Ichikawa M; Koh CS; Inoue A; Itoh M; Kyogashima M; Komiyama A
Cell Immunol; 1999 Dec; 198(2):96-102. PubMed ID: 10648123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
